open
Terapia-alueet
Back
Terapia-alueet
AL amyloidoosi
Masennus
Immunologia
Onkologia
Keuhkoverenpainetauti (PAH)
Hematologia
Muita mielenkiintoisia linkkejä
Lähetä meille sähköpostia
Soita meille
Tuotteet
Back
Tuotteet
Spravato
®
Tremfya
®
Stelara
®
Ponvory
®
Erleada
®
Uptravi
®
Darzalex
®
Imbruvica
®
Muita mielenkiintoisia linkkejä
Lähetä meille sähköpostia
Soita meille
Potilassivusto
Ota yhteyttä
Muita mielenkiintoisia linkkejä
Lähetä meille sähköpostia
Soita meille
Why should we use measurement-based care in the treatment of schizophrenia?
Media Center
Speakers
Prof. Christoph
Categories / tags
Schizophrenia
Related media
What are the considerations when choosing an antipsychotic?
Schizophrenia
Video
How to guide schizophrenia patients to accept long-acting antipsychotics?
Schizophrenia
Video
What is the optimal dose of antipsychotics?
Schizophrenia
Video
Do the benefits of long-acting treatments outweigh the concerns?
Schizophrenia
Video
Where do you see the biggest risk of relapse?
Schizophrenia
Video
Balance efficacy and tolerability for optimal maintenance treatment.
Schizophrenia
Video
Which factors need to be considered when choosing an antipsychotic?
Schizophrenia
Video
What does recovery mean for schizophrenia patients?
Schizophrenia
Video
How do you overcome the challenges of a missed dose?
Schizophrenia
Video
How can we address the underusage of long-acting treatments?
Schizophrenia
Video
What is your view on first and second generation drugs?
Schizophrenia
Video
Who are the most vulnerable patients in the COVID-19 pandemic?
Schizophrenia
Video
How can relapses in schizophrenia be prevented?
Schizophrenia
Video
What are the main risks of COVID-19 for patients with schizophrenia?
Schizophrenia
Video
Prof. David Taylor discusses the impact of COVID-19 on patients with schizophrenia.
Schizophrenia
Video
See all related